Your browser doesn't support javascript.
loading
Phase I Study of Enavatuzumab, a First-in-Class Humanized Monoclonal Antibody Targeting the TWEAK Receptor, in Patients with Advanced Solid Tumors.
Lam, Elaine T; Eckhardt, S Gail; Messersmith, Wells; Jimeno, Antonio; O'Bryant, Cindy L; Ramanathan, Ramesh K; Weiss, Glen J; Chadha, Manpreet; Oey, Abbie; Ding, Han Ting; Culp, Patricia A; Keller, Stephan F; Zhao, Vivian Y; Tsao, L Claire; Singhal, Anil; Holen, Kyle D; Von Hoff, Daniel.
Affiliation
  • Lam ET; University of Colorado at Denver, Anschutz Medical Campus, Aurora, Colorado. elaine.lam@ucdenver.edu.
  • Eckhardt SG; University of Colorado at Denver, Anschutz Medical Campus, Aurora, Colorado.
  • Messersmith W; University of Colorado at Denver, Anschutz Medical Campus, Aurora, Colorado.
  • Jimeno A; University of Colorado at Denver, Anschutz Medical Campus, Aurora, Colorado.
  • O'Bryant CL; University of Colorado at Denver, Anschutz Medical Campus, Aurora, Colorado.
  • Ramanathan RK; Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona.
  • Weiss GJ; Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona.
  • Chadha M; Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona.
  • Oey A; AbbVie Biotherapeutics Inc., Redwood City, California.
  • Ding HT; AbbVie Biotherapeutics Inc., Redwood City, California.
  • Culp PA; AbbVie Biotherapeutics Inc., Redwood City, California.
  • Keller SF; AbbVie Biotherapeutics Inc., Redwood City, California.
  • Zhao VY; AbbVie Biotherapeutics Inc., Redwood City, California.
  • Tsao LC; AbbVie Biotherapeutics Inc., Redwood City, California.
  • Singhal A; AbbVie Biotherapeutics Inc., Redwood City, California.
  • Holen KD; AbbVie Laboratories, Abbott Park, Illinois.
  • Von Hoff D; Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona.
Mol Cancer Ther ; 17(1): 215-221, 2018 01.
Article in En | MEDLINE | ID: mdl-29054986

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / TWEAK Receptor / Antibodies, Monoclonal / Neoplasms Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2018 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / TWEAK Receptor / Antibodies, Monoclonal / Neoplasms Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2018 Type: Article